NCT03754257

Brief Summary

Background: Electrical stimulation has been used in critical patients as an adjunct strategy of early rehabilitation. In septic or septic shock patients there are reports of only two studies in the literature, with conflicting results. Objective: To evaluate the effects of electrical stimulation in the prevention of muscle mass loss in patients admitted to the ICU with systemic inflammatory response syndrome (SIRS), sepsis or septic shock. Methods: This is a randomized, controlled, double-blind clinical trial. Thirty-six patients with a diagnosis of SIRS, sepsis or septic shock (including patients with sepsis due to the new coronavirus - COVID-19) will be randomly assigned to experimental group and sham group. They will be evaluated in relation to muscle mass, peripheral muscle strength and functional status. They will also be submitted to the collection of inflammatory, metabolic, damage and muscular trophism markers. Expected results: Electrical stimulation is expected to be able to prevent loss of muscle mass in patients admitted to the ICU with SIRS, sepsis or septic shock. In addition, it is expected to be able to preserve strength in this population without increasing the pro-inflammatory or metabolic response.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for not_applicable sepsis

Timeline
Completed

Started Oct 2018

Longer than P75 for not_applicable sepsis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2018

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

October 24, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 27, 2018

Completed
5.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2024

Completed
Last Updated

October 29, 2024

Status Verified

October 1, 2024

Enrollment Period

6.1 years

First QC Date

October 24, 2018

Last Update Submit

October 26, 2024

Conditions

Keywords

sepsisseptic shockelectrical stimulation

Outcome Measures

Primary Outcomes (2)

  • Muscle mass

    Cross-sectional area

    8 days

  • Muscle mass

    Thickness

    8 days

Secondary Outcomes (13)

  • Peripheral muscle strength

    8 days

  • Functional status

    8 days

  • Inflammatory

    5 days

  • Inflammatory

    5 days

  • Inflammatory

    5 days

  • +8 more secondary outcomes

Study Arms (2)

Experimental Electrical Stimulation

EXPERIMENTAL

Experimental Electrical Stimulation for 40 minutos + conventional physiotherapy, during seven days.

Procedure: Experimental Electrical StimulationOther: Conventional Physiotherapy

Sham Electrical Stimulation

SHAM COMPARATOR

Sham Electrical Stimulation for 40 minutes + conventional physiotherapy, during seven days.

Procedure: Sham Electrical StimulationOther: Conventional Physiotherapy

Interventions

Experimental Electrical Stimulation (100Hz) during 40 minutes

Experimental Electrical Stimulation

Sham Electrical Stimulation (5Hz) during 40 minutes

Sham Electrical Stimulation

Active and passive exercises, and walking.

Experimental Electrical StimulationSham Electrical Stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients admitted to the ICU with a diagnosis of SIRS, sepsis or septic shock,
  • aged ≥ 18 years,
  • body mass index (BMI) ≤ 35 kg / m2,
  • without diabetic polyneuropathy,
  • without cardiac pacemaker,
  • without diagnosis of neuromuscular diseases,
  • absence of skin lesions.

You may not qualify if:

  • heart attack,
  • death.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Sírio-Libanês

São Paulo, 01308050, Brazil

Location

MeSH Terms

Conditions

SepsisShock, Septic

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Wellington Pereira dos Santos Yamaguti

Study Record Dates

First Submitted

October 24, 2018

First Posted

November 27, 2018

Study Start

October 1, 2018

Primary Completion

October 21, 2024

Study Completion

October 21, 2024

Last Updated

October 29, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations